GLA and non-small cell lung carcinoma: IDC-G305 is a combination of NY-ESO-1 recombinant protein and GLA-SE, that has been tested in melanoma, ovarian cancer, renal cell cancer, and non-small cell lung cancer(NSCLC) (NCT02015416).